EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

IgA Nephropathy: Significance of IgA1-Containing Immune Complexes in Clinical Settings

Hitoshi Suzuki iD, Jan Novak iD

Journal of Clinical Medicine · 01.08.2024 · 13 (15) · 4495

DOI: 10.3390/jcm13154495 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.08.2024. Verfasst von Hitoshi Suzuki und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu 279-0021, Chiba, Japan. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, NIDDK NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IgA nephropathy (IgAN) is considered to be an autoimmune disease characterized by the formation of IgA1-containing immune complexes in the circulation and glomerular immunodeposits. Extensive research has identified multiple genetic, immunological, and environmental factors contributing to disease development and progression. The pathogenesis of IgAN is considered a multifactorial process involving the formation of immune complexes wherein aberrantly O-glycosylated IgA1 is recognized as an autoantigen. Consequently, the clinical presentation of IgAN is highly variable, with a wide spectrum of manifestations ranging from isolated microscopic hematuria or episodic macroscopic hematuria to nephrotic-range proteinuria. Whereas some patients may exhibit a slowly progressive form of IgAN, others may present with a rapidly progressive glomerulonephritis leading to kidney failure. Development of the treatment for IgAN requires an understanding of the characteristics of the pathogenic IgA1-containing immune complexes that enter the glomerular mesangium and induce kidney injury. However, not all details of the mechanisms involved in the production of galactose-deficient IgA1 and immune-complex formation are fully understood. Here, we review what we have learned about the characteristics of nephritogenic IgA1 in the half-century since the first description of IgAN in 1968.

Schlagwörter

Stichwörter der Autor:innen

IgA nephropathybiomarkergalactose-deficient IgA1immune complexes

Autor:innen und Institutionen

  • Department of Nephrology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu 279-0021, Chiba, Japan.
  • Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

ORCID-Profile: Hitoshi Suzuki, Jan Novak

Förderung

  • Japan Agency for Medical Research and Development
  • NIDDK NIH HHS
  • NIAID NIH HHS
  • Japan Society for the Promotion of Science
  • Wellcome Trust
  • Ministry of Health, Labour and Welfare of Japan
  • AMED
  • JSPS KAKENHI

Zitieren

APA

Suzuki, H., & Novak, J. (2024). IgA Nephropathy: Significance of IgA1-Containing Immune Complexes in Clinical Settings. Journal of Clinical Medicine, 13(15), 4495. https://doi.org/10.3390/jcm13154495

Vancouver

Suzuki H, Novak J. IgA Nephropathy: Significance of IgA1-Containing Immune Complexes in Clinical Settings. Journal of Clinical Medicine. 2024;13(15):4495. doi:10.3390/jcm13154495

BibTeX
@article{Suzuki2024,
  author = {Suzuki, Hitoshi and Novak, Jan},
  title = {IgA Nephropathy: Significance of IgA1-Containing Immune Complexes in Clinical Settings},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {15},
  pages = {4495},
  doi = {10.3390/jcm13154495}
}
Kostenlos starten →